Caracterização e isolamento de compostos bioactivos do fungo Laurobasidium lauri (Madre de louro)

Os objectivos deste trabalho consistiram em desenvolver um método de separação eficaz e reprodutível de modo a isolar as lactonas sesquiterpénicas - dehidrocostus e costunolida - de extractos do fungo parasita da espécie Laurus novocanariensis - Laurobasidium lauri; em testar os compostos relativamente às suas capacidades antioxidantes e bioactivas - citotoxicidade e alelopatia - e em obter uma quantidade considerável destas lactonas de modo a enviar para laboratórios em parceria para realização de testes de actividade anticancerígena in vitro (Instituto Canário de Investigação em Cancro), de antituberculose in vivo (Instituto politécnico Nacional, México), de actividade anti-inflamatória in vivo (UNIVALI, Brasil) e de actividade anti-ulcerativa in vivo. Neste trabalho foi possível isolar 116 mg de lactona costunolida com 97% de pureza através do fraccionamento do extracto de Madre de Louro em hexano pela técnica de cromatografia em coluna aberta com sistema de eluentes Hexano:Acetato de etilo (50:0 – 43:7 mL), procedendo à sua identificação por HPLC-MS e RMN 13C, não tendo sido possível atingir o mesmo objectivo para a lactona dehidrocostus. O extracto de Madre de Louro em Metanol demonstrou ser a amostra com maior poder antioxidante relativamente aos teste de ABTS, DPPH e FRAP, enquanto o extracto em Diclorometano apresentou maior poder antioxidante no teste do β-caroteno/ácido linoléico. No que toca aos ensaios biológicos, o extracto de madre de louro em hexano foi o que apresentou um valor de DL50 mais baixo (0,1mg/mL) representando assim maior poder de toxicidade perante as larvas de camarão (Artemia salina).

Integrated valorization of Anona Cherimola Mill. seeds

Agricultural and agro-industrial residues are often considered both an environmental and an economical problem. Therefore, a paradigm shift is needed, assuming residues as biorefinery feedstocks. In this work cherimoya (Annona cherimola Mill.) seeds, which are lipid-rich (ca. 30%) and have a significant lignocellulosic fraction, were used as an example of a residue without any current valorization. Firstly, the lipid fraction was obtained by solvent extraction. Extraction yield varied from 13% to 28%, according to the extraction method and time, and solvent purity. This oil was converted into biodiesel (by base-catalyzed transesterification), yielding 76 g FAME/100 g oil. The obtained biodiesel is likely to be incorporated in the commercial chain, according to the EN14214 standard. The remaining lignocellulosic fraction was subjected to two alternative fractionation processes for the selective recovery of hemicellulose, aiming different products. Empirical mathematical models were developed for both processes, aiming future scale-up. Autohydrolysis rendered essentially oligosaccharides (10 gL-1) with properties indicating potential food/feed/pharmacological applications. The remaining solid was enzymatically saccharified, reaching a saccharification yield of 83%. The hydrolyzate obtained by dilute acid hydrolysis contained mostly monosaccharides, mainly xylose (26 gL-1), glucose (10 gL-1) and arabinose (3 gL-1), and had low content of microbial growth inhibitors. This hydrolyzate has proven to be appropriate to be used as culture media for exopolisaccharide production, using bacteria or microbial consortia. The maximum conversion of monosaccharides into xanthan gum was 0.87 g/g and kefiran maximum productivity was 0.07 g.(Lh)-1. This work shows the technical feasibility of using cherimoya seeds, and materials as such, as potential feedstocks, opening new perspectives for upgrading them in the biorefinery framework.

Use of novel biomarkers (Homocysteine, vitamin B6, B9 and B12) on the assessing the progression of cardiovascular disease

A large number of evidences correlate elevated levels of homocysteine (Hcys) with a higher cardiovascular diseases (CVDs) risk, especially, atherosclerosis. Similarly, abnormal low levels of the vitamins B6, B9 and B12 are associated to an instability in the methionine cycle with an over production of Hcys. Thus, biomedical sciences are looking forward for a cheaper, faster, precise and accurate analytical methodology to quantify these compounds in a suitable format for the clinical environment. Therefore the objective of this study was the development of a simple, inexpensive and appropriate methodology to use at the clinical level. To achieve this goal, a procedure integrating a digitally controlled (eVol®) microextraction by packed sorbent (MEPS) and an ultra performance liquid chromatography (UPLC) coupled to a photodiode array detector (PDA) was developed to identify and quantify Hcys vitamins B6, B9 and B12. Although different conditions were assayed, we were not able to combine Hcys with the vitamins in the same analytical procedure, and so we proceeded to the optimization of two methods differing only in the composition of the gradient of the mobile phase and the injected volume. It was found that MEPS did not bring any benefit to the quantification of the Hcys in the plasma. Therefore, we developed and validate an alternative method that uses the direct injection of treated plasma (reduced and precipitated). This same method was evaluated in terms of selectivity, linearity, limit of detection (LOD), limit of quantification (LOQ), matrix effect and precision (intra-and inter-day) and applied to the determination of Hcys in a group composed by patients presenting augmented CVD risk. Good results in terms of selectivity and linearity (R2> 0.9968) were obtained, being the values of LOD and LOQ 0.007 and 0.21 mol / L, respectively. The intra-day precision (1.23-3.32%), inter-day precision (5.43-6.99%) and the recovery rate (82.5 to 93.1%) of this method were satisfactory. The matrix effect (>120%) was, however, higher than we were waiting for. Using this methodology it was possible to determine the amount of Hcys in real plasma samples from individuals presenting augmented CVD risk. Regarding the methodology developed for vitamins, despite the optimization of the extraction technique and the chromatographic conditions, it was found that the levels usually present in plasma are far below the sensitivity we obtained. Therefore, further optimizations of the methodology developed are needed. As conclusion, part of the objectives of this study was achieved with the development of a quick, simple and cheaper method for the quantification of Hcys.